OrthoPediatrics (NASDAQ:KIDS) Price Target Lowered to $32.00 at Stifel Nicolaus

OrthoPediatrics (NASDAQ:KIDS) had its target price decreased by Stifel Nicolaus from $40.00 to $32.00 in a report released on Wednesday morning,Benzinga reports. Stifel Nicolaus currently has a buy rating on the stock.

Several other analysts have also recently weighed in on the stock. Truist Financial lowered their price objective on shares of OrthoPediatrics from $28.00 to $25.00 and set a “hold” rating on the stock in a research report on Wednesday, December 18th. Needham & Company LLC reiterated a “buy” rating and issued a $42.00 target price on shares of OrthoPediatrics in a research report on Wednesday.

OrthoPediatrics Stock Performance

OrthoPediatrics stock opened at $25.61 on Wednesday. The firm’s fifty day moving average price is $24.39 and its 200-day moving average price is $25.94. The company has a debt-to-equity ratio of 0.19, a quick ratio of 3.68 and a current ratio of 7.17. The stock has a market cap of $620.17 million, a P/E ratio of -20.82 and a beta of 1.14. OrthoPediatrics has a fifty-two week low of $21.02 and a fifty-two week high of $35.99.

OrthoPediatrics (NASDAQ:KIDS) last posted its quarterly earnings data on Tuesday, March 4th. The company reported ($0.29) earnings per share for the quarter, beating the consensus estimate of ($0.33) by $0.04. The firm had revenue of $52.67 million for the quarter, compared to analysts’ expectations of $51.16 million. OrthoPediatrics had a negative net margin of 15.00% and a negative return on equity of 5.78%. During the same quarter last year, the company posted ($0.23) EPS. On average, equities research analysts expect that OrthoPediatrics will post -0.93 earnings per share for the current fiscal year.

Hedge Funds Weigh In On OrthoPediatrics

A number of large investors have recently added to or reduced their stakes in the business. AWM Investment Company Inc. raised its position in OrthoPediatrics by 14.8% in the 4th quarter. AWM Investment Company Inc. now owns 516,794 shares of the company’s stock worth $11,979,000 after purchasing an additional 66,779 shares during the period. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC grew its holdings in OrthoPediatrics by 76.8% in the 4th quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 19,863 shares of the company’s stock worth $460,000 after acquiring an additional 8,631 shares during the last quarter. Point72 Asset Management L.P. bought a new stake in OrthoPediatrics in the 4th quarter worth $7,450,000. Numerai GP LLC bought a new stake in OrthoPediatrics in the 4th quarter worth $372,000. Finally, OCONNOR A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS LLC grew its holdings in OrthoPediatrics by 25.5% in the 4th quarter. OCONNOR A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 65,292 shares of the company’s stock worth $1,513,000 after acquiring an additional 13,270 shares during the last quarter. Hedge funds and other institutional investors own 69.05% of the company’s stock.

OrthoPediatrics Company Profile

OrthoPediatrics Corp., a medical device company, engages in designing, developing, and marketing anatomically appropriate implants, instruments, and specialized braces for children with orthopedic conditions in the United States and internationally. The company offers pediatric trauma and deformity correction products; scoliosis procedures for the treatment of spinal deformity; and sports medicine and other products.